Cannakeys

Unlocking the Science of Cannabis

Fatty Acid Amide Hydrolase (FAAH) Cannabinoid Research

Fatty Acid Amide Hydrolase (FAAH) Research Dashboard

68

Primary Studies

113

Related Studies

181

Total Studies

Clinical Studies

1

Clinical Meta-analyses

0

Double-blind human trials

5

Clinical human trials

Pre-Clinical Studies

18

Meta-analyses/Reviews

30

Animal studies

10

Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 181 studies associated with Fatty Acid Amide Hydrolase (FAAH).

Here is a small sampling of Fatty Acid Amide Hydrolase (FAAH) studies by title:

  • Cannabinoids: Therapeutic Use in Clinical Practice
  • URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors
  • Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer's Disease Patients
  • Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review
  • Cannabinoid receptor type 2 gene is associated with comorbidity of schizophrenia and cannabis dependence and fatty acid amide hydrolase gene is associated with cannabis dependence in the Spanish population

Components of the Fatty Acid Amide Hydrolase (FAAH) Research Dashboard

  • Top medical conditions associated with Fatty Acid Amide Hydrolase (FAAH)
  • Proven effects in clinical trials for Fatty Acid Amide Hydrolase (FAAH)
  • Receptors associated with Fatty Acid Amide Hydrolase (FAAH)
  • Individual study details for Fatty Acid Amide Hydrolase (FAAH)

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Fatty Acid Amide Hydrolase (FAAH)

Description of Fatty Acid Amide Hydrolase (FAAH)

The naturally occurring enzyme fatty acid amide hydrolase (FAAH) breaks down anandamide and thus increases its bio-availability.

Other Names:

Fatty Acid Amide Hydrolase

Fatty Acid Amide Hydrolase (FAAH) Properties and Effects

Inhibition of FAAH produces analgesic, anti-inflammatory, and mood improving effects

Fatty Acid Amide Hydrolase (FAAH) Receptor Binding

Not Applicable as FAAH does not bind with receptor sites
Top  

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.